TickerFacts.

A business in context

BBIO research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-08 · 8005 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-08-31 · 0001140361-26-035055 · Items 8.01,9.01

  2. 4 · Ownership change

    Report date 2026-08-18 · 0001470831-26-000848

  3. 4 · Ownership change

    Report date 2026-08-16 · 0001470831-26-000837

  4. 4 · Ownership change

    Report date 2026-08-16 · 0001470831-26-000836

  5. 4 · Ownership change

    Report date 2026-08-16 · 0001470831-26-000835

  6. 8-K · Current report

    Report date 2026-08-13 · 0001140361-26-033282 · Items 1.01,8.01,9.01

  7. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001743881-26-000027

  8. 8-K · Current report

    Report date 2026-08-10 · 0001743881-26-000026 · Items 2.02,9.01

  9. 4 · Ownership change

    Report date 2026-07-30 · 0001470831-26-000745

  10. 8-K · Current report

    Report date 2026-07-22 · 0001140361-26-029291 · Items 8.01,9.01

  11. 4 · Ownership change

    Report date 2026-07-09 · 0001470831-26-000709

  12. 4 · Ownership change

    Report date 2026-07-09 · 0001470831-26-000708

  13. 8-K · Current report

    Report date 2026-07-01 · 0001140361-26-027445 · Items 1.01,3.02,3.03,5.03,7.01,9.01

  14. 8-K · Current report

    Report date 2026-06-22 · 0001140361-26-026506 · Items 5.02,5.07,9.01

  15. 4 · Ownership change

    Report date 2026-06-22 · 0001470831-26-000636

  16. 8-K · Current report

    Report date 2026-05-27 · 0001140361-26-022979 · Items 8.01,9.01

  17. 8-K · Current report

    Report date 2026-05-12 · 0001140361-26-021036 · Items 8.01,9.01

  18. 8-K · Current report

    Report date 2026-05-07 · 0001140361-26-019761 · Items 1.01,1.02,9.01

  19. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001743881-26-000019

  20. 8-K · Current report

    Report date 2026-05-06 · 0001743881-26-000018 · Items 2.02,8.01

  21. DEF 14A · Proxy statement

    Report date 2026-06-22 · 0001140361-26-016723

  22. 8-K · Current report

    Report date 2026-03-30 · 0001140361-26-011991 · Items 8.01,9.01

  23. 10-K · Annual report

    Report date 2025-12-31 · 0001743881-26-000009

  24. 8-K · Current report

    Report date 2026-02-24 · 0001743881-26-000008 · Items 2.02,9.01

  25. 8-K · Current report

    Report date 2026-02-12 · 0001140361-26-004995 · Items 8.01,9.01

  26. 8-K · Current report

    Report date 2026-01-14 · 0001140361-26-001843 · Items 1.01,2.03,3.02,8.01,9.01

  27. 8-K · Current report

    Report date 2026-01-12 · 0001140361-26-000971 · Items 2.02,7.01,8.01,9.01

  28. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001743881-25-000012

  29. 8-K · Current report

    Report date 2025-10-29 · 0001743881-25-000010 · Items 2.02,9.01

  30. 8-K · Current report

    Report date 2025-10-29 · 0001140361-25-039705 · Items 8.01,9.01

  31. 8-K · Current report

    Report date 2025-10-27 · 0001140361-25-039463 · Items 8.01,9.01

  32. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-103192

  33. 8-K · Current report

    Report date 2025-08-05 · 0000950170-25-102985 · Items 2.02,9.01

  34. 8-K · Current report

    Report date 2025-06-27 · 0001140361-25-024413 · Items 1.01,2.03

  35. 8-K · Current report

    Report date 2025-06-20 · 0001140361-25-023362 · Items 3.03,5.03,5.07,9.01

  36. DEF 14A · Proxy statement

    Report date 2025-06-20 · 0001140361-25-016452

  37. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-060314

  38. 8-K · Current report

    Report date 2025-04-29 · 0000950170-25-060085 · Items 2.02,9.01

  39. 8-K · Current report

    Report date 2025-03-17 · 0001140361-25-009063 · Items 5.02,7.01,9.01

  40. 8-K · Current report

    Report date 2025-02-24 · 0001140361-25-006524 · Items 1.01,1.02,2.03,3.02,8.01,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 52 transaction rows52SGrant / award: 24 transaction rows24AExercise / conversion: 20 transaction rows20MTax / exercise payment: 4 transaction rows4FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

100 matching transaction rows. Showing 51–100.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-04
2026-06-08
Kumar Neil
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock450.068.27
2026-06-04
2026-06-08
Kumar Neil
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock2200.065.72
2026-06-04
2026-06-08
Kumar Neil
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1429.066.72
2026-06-04
2026-06-08
Kumar Neil
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock15921.067.74
2026-06-04
2026-06-08
Kumar Neil
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock450.068.27
2026-05-21
2026-05-26
Kumar Neil
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock800.070.92
2026-05-21
2026-05-26
Kumar Neil
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock2256.067.57
2026-05-21
2026-05-26
Kumar Neil
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock6725.068.3
2026-05-21
2026-05-26
Kumar Neil
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock5072.069.22
2026-05-21
2026-05-26
Kumar Neil
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock11250.070.48
2026-05-18
2026-05-19
Trimarchi Thomas
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock10456.064.82
2026-05-18
2026-05-19
Trimarchi Thomas
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock3195.065.95
2026-05-16
2026-05-19
Trimarchi Thomas
10b5-1 checkbox reported
F · Tax / exercise payment
Disposed
Common Stock22781.066.13
2026-05-16
2026-05-19
Kumar NeilM · Exercise / conversion
Acquired
Common Stock33544.0—
2026-05-16
2026-05-19
Kumar NeilM · Exercise / conversion
Acquired
Common Stock19599.0—
2026-05-16
2026-05-19
Kumar NeilF · Tax / exercise payment
Disposed
Common Stock36236.066.13
2026-05-16
2026-05-19
Kumar NeilM · Exercise / conversion
Acquired
Common Stock6519.0—
2026-05-16
2026-05-19
Kumar NeilM · Exercise / conversion
Acquired
Common Stock11553.0—
2026-05-16
2026-05-19
Kumar NeilM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
6519.00.0
2026-05-16
2026-05-19
Kumar NeilM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
33544.00.0
2026-05-16
2026-05-19
Kumar NeilM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
11553.00.0
2026-05-16
2026-05-19
Kumar NeilM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
19599.00.0
2026-05-16
2026-05-19
Apuli MaricelF · Tax / exercise payment
Disposed
Common Stock4714.066.13
2026-05-15
2026-05-19
Scott Randal W.
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock200.069.12
2026-05-15
2026-05-19
Scott Randal W.
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock2088.067.53
2026-05-15
2026-05-19
Scott Randal W.
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1512.068.23
2026-05-15
2026-05-19
Scott Randal W.
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock10000.016.75
2026-05-15
2026-05-19
Scott Randal W.
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock6200.066.69
2026-05-15
2026-05-19
Scott Randal W.
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
10000.00.0
2026-05-08
2026-05-11
Kumar Neil
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock13973.066.65
2026-05-08
2026-05-11
Kumar Neil
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock5077.067.35
2026-05-08
2026-05-11
Kumar Neil
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock950.068.35
2026-05-08
2026-05-11
Kumar Neil
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock13974.066.65
2026-05-08
2026-05-11
Kumar Neil
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock5076.067.35
2026-05-08
2026-05-11
Kumar Neil
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock950.068.35
2026-05-07
2026-05-11
Kumar Neil
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock8333.068.38
2026-05-07
2026-05-11
Kumar Neil
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock450.069.09
2026-05-07
2026-05-11
Kumar Neil
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock11217.067.49
2026-05-07
2026-05-11
Kumar Neil
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock8334.068.38
2026-05-07
2026-05-11
Kumar Neil
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock11217.067.5
2026-05-07
2026-05-11
Kumar Neil
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock449.069.09
2026-04-30
2026-05-04
Apuli Maricel
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock2000.071.58
2026-04-10
2026-04-13
Kumar Neil
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock20000.074.6
2026-04-10
2026-04-13
Kumar Neil
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock20000.074.6
2026-04-09
2026-04-13
Kumar Neil
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock7200.073.64
2026-04-09
2026-04-13
Kumar Neil
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock7800.075.53
2026-04-09
2026-04-13
Kumar Neil
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock5128.074.57
2026-04-09
2026-04-13
Kumar Neil
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock7072.073.64
2026-04-09
2026-04-13
Kumar Neil
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock7500.075.55
2026-04-09
2026-04-13
Kumar Neil
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock5300.074.6

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001743881BridgeBio Pharma, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names
  • BridgeBio Pharma LLC · former SEC name · 2018-06-19 to 2019-05-16

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$221.90M$236.21M
2023-12-31$9.30M$10.19M
2022-12-31$77.65M$88.58M
2021-12-31$69.72M$85.90M
2020-12-31$8.25M$10.64M
2019-12-31$40.56M$52.97M

Bureau of Labor Statistics · retrieved 2026-09-08 · 9 selected series; gaps remain missing

Explore the CPI history ↗